Conditions: Type II Diabetes Mellitus Dyslipidemia
Keywords: Pitavastatin Type II Diabetes Mellitus Combined Dyslipidemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 214
Healthy volunteers: no

Brief summary:
This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.

Detailed description:

Arms:
arm 1: Pitavastatin 4 mg QD arm 2: Atorvastatin 40 mg

Interventions: intervention 1: Pitavastatin intervention 2: Atorvastatin
Intervention descriptions: intervention 1: Pitavastatin 4 mg QD intervention 2: Atorvastatin 40 mg

Protocol document: